Fatima Laher

3.2k citations

51 papers · 1.1k indexed · h-index 20

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in

Virology 16
- HIV Research and Treatment 16
Infectious Diseases 28
- HIV/AIDS Research and Interventions 26

Co-authors: Glenda Gray Angela Kaida Lerato Mohapi Robert S. Hogg Janan Dietrich Patricia A. Janssen Deborah Money Steffanie A. Strathdee
Journals: PLoS ONE (9 papers)AIDS and Behavior (6 papers)Scientific Reports (2 papers)BMC Infectious Diseases (2 papers)BMC Public Health (2 papers)
Partner nations: South Africa United States Canada

In The Last Decade

Fatima Laher

48 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fatima Laher

Since Specialization

Citations

This map shows the geographic impact of Fatima Laher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Laher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Laher more than expected).

Fields of papers citing papers by Fatima Laher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatima Laher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Laher. The network helps show where Fatima Laher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fatima Laher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fatima Laher Line = papers co-authored together Fatima Laher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acceptability of Hypothetical HIV Cure-Related Research Modalities: A Cross-Sectional Study of People Living with HIV in Soweto, South Africa AIDS Research and Human Retroviruses ·Fatima Laher, R. Weiler, Ashley L. Funk, Dionys Morais dos Santos	2025	1
2	Beliefs about HIV cure: A qualitative study of people living with HIV in Soweto, South Africa Southern African Journal of HIV Medicine ·Fatima Laher, Ashley L. Funk, R. Weiler	2025	2
3	Male circumcision perceptions among HIV vaccine trial participants in Soweto: Qualitative study SHILAP Revista de lepidopterología ·R. Weiler, Fatima Laher, H. L., Marek Lis, Rodak Tomasz, Stefanie Hornschuh, Hong‐Van Tieu, Janan Dietrich	2024	0
4	Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702 Vaccine ·Lara de Vito, Jia Jin Kee, Zoe Moodie, Yunda Huang, Holly Janes, Sufia Dadabhai, Alison C. Roxby, Mary Allen, Helge Seetzen, 精之助久田, Craig Innes, Nivashnee Naicker, Anika Tabassum, Nicole Grunenberg, Mookho Malahleha, James G. Kublin, Linda‐Gail Bekker, Glenda Gray, Johnstone Kumwenda, Fatima Laher	2024	1
5	Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa AIDS and Behavior ·Fatima Laher, Kennedy Otwombe, C. N. Blumenthal, Linda‐Gail Bekker, Mary Allen	2022	0
6	Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry South African Medical Journal ·Lianna Giselle Chaves Cano, Fatima Laher, N.A. Mishio, Mariëtte Nel, Heni Kurnianti, Barry Jacobson	2021	2
7	Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk PLoS Pathogens ·Erica Andersen‐Nissen, Andrew Fioré-Gartland, Lamar Ballweber-Fleming, Lindsay N. Carpp, 天成, Michael S. Harper, Valentin Voillet, Nicole Grunenberg, Fatima Laher, Craig Innes, Linda‐Gail Bekker, James G. Kublin, Ying Huang, Guido Ferrari, Georgia D. Tomaras, Glenda Gray, Peter B. Gilbert, M. Juliana McElrath	2021	20
8	An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis BMC Infectious Diseases ·Harold Marcotte, P.‐G. Larsson, Kasper Krogh Andersen, Fanglei Zuo, 果織大嶋, Erik Brandsborg, Glenda Gray, Fatima Laher, Kennedy Otwombe	2019	31
9	Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa Southern African Journal of HIV Medicine ·Erica Lazarus, Kennedy Otwombe, Janan Dietrich, Michele Andrasik, Cecilia Morgan, James G. Kublin, Glenda Gray, Abby Isaacs, Fatima Laher	2019	2
10	Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells Frontiers in Immunology ·Leigh H. Fisher, 昌美花房, Sherry Stanfield-Oakley, Lindsay N. Carpp, R. Whitney Edwards, Thomas N. Denny, Zoe Moodie, Fatima Laher, Linda‐Gail Bekker, M. Juliana McElrath, Peter B. Gilbert, Lawrence Corey, Georgia D. Tomaras, Justin Pollara, Guido Ferrari	2019	23
11	Investigating Sociodemographic Factors and HIV Risk Behaviors Associated With Social Networking Among Adolescents in Soweto, South Africa: A Cross-Sectional Survey JMIR Public Health and Surveillance ·Janan Dietrich, Fatima Laher, Stefanie Hornschuh, Busisiwe Nkala, Lucy Chimoyi, Kennedy Otwombe, Angela Kaida, Glenda Gray, Cari L. Miller	2016	8
12	Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men PLoS ONE ·Zoe Moodie, Barbara Metch, Linda‐Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng, Koleka Mlisana, Fatima Laher, Surita Roux, Kathryn Mngadi, Craig Innes, Matsontso Mathebula, Mary Allen, Carter Bentley, Peter B. Gilbert, Michael Robertson, James G. Kublin, Lawrence Corey, Glenda Gray	2015	25
13	Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study The Lancet Infectious Diseases ·Glenda Gray, Zoe Moodie, Barbara Metch, Peter B. Gilbert, Linda‐Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng, Koleka Mlisana, Fatima Laher, Surita Roux, Kathryn Mngadi, Craig Innes, Matsontso Mathebula, Mary Allen, S Duk, Michael Robertson, James G. Kublin, Lawrence Corey	2014	82
14	Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa PLoS ONE ·Erica Lazarus, Kennedy Otwombe, 寛多田, 正彦山野, Glenda Gray, Nicole Grunenberg, Surita Roux, Gavin Churchyard, Craig Innes, Fatima Laher	2014	4
15	Does routine prophylactic oral flucloxacillin reduce the incidence of post-circumcision infections? American Journal of Infection Control ·Limakatso Lebina, Fatima Laher, 朱新贵, H. Li, Kennedy Otwombe, Glenda Gray, Neil Martinson	2013	7
16	The Effect of a Maturing Antiretroviral Program on Early Mortality for Patients with Advanced Immune-Suppression in Soweto, South Africa PLoS ONE ·Kennedy Otwombe, Fatima Laher, Ηλίας Λούκας, Glenda Gray, Lerato Mohapi	2013	7
17	Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa PLoS ONE ·Ziad El‐Khatib, David Katzenstein, Gaetano Marrone, Fatima Laher, Lerato Mohapi, Max Petzold, Lynn Morris, Anna Mia Ekström	2011	86
18	Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa Contraception ·Fatima Laher, Catherine S. Todd, Mark Stibich, R. Roosen, A. H. C., Lerato Mohapi, Neil Martinson, Glenda Gray	2010	20
19	Influence of Culture on Contraceptive Utilization Among HIV-Positive Women in Brazil, Kenya, and South Africa AIDS and Behavior ·Catherine S. Todd, Mark Stibich, Fatima Laher, Mônica Malta, Francisco Inácio Bastos, Mahmut Kaplan, Douglas Shaffer, Samuel Sinei, Glenda Gray	2010	27
20	A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions among HIV-Positive Women in Soweto, South Africa AIDS and Behavior ·Fatima Laher, Catherine S. Todd, Mark Stibich, R. Roosen, A. H. C., Lerato Mohapi, Glenda Gray	2009	63

About Fatima Laher

Fatima Laher is a scholar working on Virology, Infectious Diseases, General Health Professions, Microbiology and Epidemiology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (26 papers), Adolescent Sexual and Reproductive Health (22 papers), HIV Research and Treatment (16 papers), Reproductive tract infections research (6 papers), HIV, Drug Use, Sexual Risk (6 papers), Hepatitis B Virus Studies (5 papers), vaccines and immunoinformatics approaches (4 papers) and Genital Health and Disease (4 papers). The work is most often cited by research in Virology (316 citations), Infectious Diseases (731 citations), General Health Professions (476 citations), Microbiology (84 citations) and Pediatrics, Perinatology and Child Health (182 citations). Fatima Laher has collaborated with scholars based in South Africa, United States and Canada. Frequent co-authors include Glenda Gray, Angela Kaida, Lerato Mohapi, Robert S. Hogg, Janan Dietrich, Patricia A. Janssen, Deborah Money, Steffanie A. Strathdee, Erica Lazarus and Ziad El‐Khatib. Their work appears in journals such as PLoS ONE, AIDS and Behavior, Scientific Reports, BMC Infectious Diseases and BMC Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact